Express Scripts (NASDAQ:ESRX)

Business and authority

The Worst Companies To Work For

 These days, employees can easily share their work experiences online, and employee opinions about companies and managers are all readily available to prospective workers and customers alike. As a result, ...
Read Full Story »
nasdaq-logo

The 6 Most Heavily Shorted Nasdaq Stocks in June

Between the May 15 and May 29 settlement dates, Sirius XM was dethroned as the most heavily shorted stock traded on the Nasdaq. A surge in short interest pushed Frontier ...
Read Full Story »
NASDAQ_stock_market

The 6 Most Shorted Nasdaq Stocks in May

Between the May 15 and May 29 settlement dates, biotech stock MannKind continued its climb up the ranks of the most heavily shorted stocks traded on the Nasdaq. It threatens ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Ambev, CTI Bio, Duke, Humana, Occidental, Yelp and More

Stocks were indicated higher on Monday after last week's selling. The culprit is a market rumor that Greece may reach a debt pact today, which maybe everyone should only believe ...
Read Full Story »
nasdaq-logo

The 5 Most Shorted Nasdaq Stocks in May

The five most heavily shorted stocks traded on the Nasdaq all saw increases in short interest between the April 30 and May 15 settlement dates. That was most apparent in ...
Read Full Story »
Money background. Close-up.

9 Well-Established Companies That Just Refuse to Pay Dividends

Investors are still in love with dividends. After all, dividends can account for a large portion of total returns through time. With a bull market that is now six years old, ...
Read Full Story »
Dow Chemical logo

UBS Makes Big Changes to Equity Focus List For March

The higher the markets go, the more the major Wall Street firms are becoming content to really start taking some profits off the table and shifting allocations to stocks that ...
Read Full Story »
pills

Is Express Scripts 2015 Guidance Good Enough For All-Time Highs?

After the markets closed Monday, Express Scripts Holding Company (NASDAQ: ESRX) reported its fourth-quarter financial results as $1.39 in earnings per share (EPS) and $26.31 billion in revenue. This is ...
Read Full Story »
Buffet

Meet the 2015 Warren Buffett and Berkshire Hathaway Stocks

Berkshire Hathaway Inc. (NYSE: BRK-A) has made its quarterly filing with the Securities & Exchange Commission for its holdings as of December 31, 2014. For all practical purposes, this filing is ...
Read Full Story »
Rite Aid

Rite Aid PBM Purchase Differentiates It From CVS and Walgreens

Rite Aid Corp. (NYSE: RAD) and Envision Pharmaceutical Services (EnvisionRx) announced that they have entered into a definitive agreement in which Rite Aid will acquire EnvisionRx for $2 billion from ...
Read Full Story »
biotech

What to Expect From Gilead Earnings

Tuesday after the markets close, Gilead Sciences Inc. (NASDAQ: GILD) will report its fourth-quarter financial results. Thomson Reuters has consensus estimates of $2.22 in earnings per share (EPS) and $6.72 ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AOL, Caterpillar, Goodyear, Southwest, Synchrony, Yahoo and More

Stocks were indicated up and looking for a bounce on Wednesday morning after a big earnings and strong dollar related sell-off on the prior day. The trend for 2015 does ...
Read Full Story »
Money background. Close-up.

Gilead Continues to Recover from Express Scripts Loss

After the markets closed on Thursday, Gilead Sciences Inc. (NASDAQ: GILD) was picked up by Anthem Inc. (NYSE: ANTM) to provide its hepatitis C drug as the primary option for ...
Read Full Story »
thumbs up

Is Gilead Already Coming Back Into Favor?

Over the past year, Gilead Sciences Inc. (NASDAQ: GILD) has been a top dog with regards to hepatitis C treatments, pulling in over $6.2 billion in sales for these treatments ...
Read Full Story »
downgrade sign

Analysts Predict Big Value Trap for Gilead Investors

AbbVie Inc. (NYSE: ABBV) and Express Scripts Holding Co. (NASDAQ: ESRX) entered into an exclusive distribution agreement following the U.S. Food and Drug Administration’s (FDA) approval of AbbVie’s hepatitis C ...
Read Full Story »